Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.

Andresz V, Marcantoni N, Binder F, Velten M, Alt M, Weber JC, Stephan D.

Addiction. 2006 Sep;101(9):1347-51.

PMID:
16911735
2.

[Puffy hand in long-term intravenous drug users].

Simonnet N, Marcantoni N, Simonnet L, Griffon C, Chakfe N, Wertheimer J, Stephan D.

J Mal Vasc. 2004 Oct;29(4):201-4. French.

PMID:
15529083
3.

[Buprenorphine abuse: high dose intravenous administration of buprenorphine].

Varescon I, Vidal-Trécan G, Nabet N, Boissonnas A.

Encephale. 2002 Sep-Oct;28(5 Pt 1):397-402. French.

PMID:
12386540
4.

Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.

Guichard A, Lert F, Calderon C, Gaigi H, Maguet O, Soletti J, Brodeur JM, Richard L, Benigeri M, Zunzunegui MV.

Addiction. 2003 Nov;98(11):1585-97.

PMID:
14616185
5.

Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management.

Roux P, Villes V, Blanche J, Bry D, Spire B, Feroni I, Carrieri MP.

Drug Alcohol Depend. 2008 Sep 1;97(1-2):105-13. doi: 10.1016/j.drugalcdep.2008.03.025. Epub 2008 May 13.

PMID:
18479840
6.

Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis.

Peyrière H, Tatem L, Bories C, Pageaux GP, Blayac JP, Larrey D.

Ann Pharmacother. 2009 May;43(5):973-7. doi: 10.1345/aph.1L628. Epub 2009 Apr 21.

PMID:
19383935
7.

Effects of high-dose intravenous buprenorphine in experienced opioid abusers.

Umbricht A, Huestis MA, Cone EJ, Preston KL.

J Clin Psychopharmacol. 2004 Oct;24(5):479-87.

PMID:
15349002
8.

[Puffy hand syndrome in drug addiction treated by low-stretch bandages].

Arrault M, Vignes S.

Ann Dermatol Venereol. 2006 Oct;133(10):769-72. French.

PMID:
17072191
9.

The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended.

Nielsen S, Lintzeris N.

Addiction. 2008 Dec;103(12):2065-6. doi: 10.1111/j.1360-0443.2008.02385.x. No abstract available.

PMID:
19469751
10.

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

Carrieri MP, Rey D, Loundou A, Lepeu G, Sobel A, Obadia Y; MANIF-2000 Study Group.

Drug Alcohol Depend. 2003 Oct 24;72(1):13-21.

PMID:
14563539
11.
12.

[Psychopathology of the misuse of Subutex®: The Popeye syndrome].

Békaert J, Podevin G.

Encephale. 2015 Jun;41(3):229-37. doi: 10.1016/j.encep.2014.08.009. Epub 2014 Sep 16. French.

PMID:
25212472
13.

Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

Vidal-Trecan G, Varescon I, Nabet N, Boissonnas A.

Drug Alcohol Depend. 2003 Mar 1;69(2):175-81.

PMID:
12609698
14.

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.

Addiction. 2007 Apr;102(4):616-22. Epub 2007 Feb 6.

PMID:
17286641
15.

Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.

Hakansson A, Medvedeo A, Andersson M, Berglund M.

Eur Addict Res. 2007;13(4):207-15.

PMID:
17851242
16.

[Puffy hand syndrome].

Arrault M, Gaouar F, Vignes S.

Rev Med Interne. 2009 May;30(5):460-4. doi: 10.1016/j.revmed.2008.11.011. Epub 2009 Feb 11. Review. French.

PMID:
19216010
17.

[High dosage buprenorphine and injection practices. A study of 303 patients].

Courty P.

Ann Med Interne (Paris). 2003 Jun;154 Spec No 1:S35-45. French.

PMID:
12910032
18.

[Can we stop the hepatitis C virus transmission in drug users?].

Lert F.

Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S61-1S67. Review. French.

PMID:
17073131
19.

[Puffy hand syndrome due to drug addiction. Chronic lymphoedema and long-term intravenous drug addiction].

Messikh R, Pelletier F, Bizouard N, Aubin F, Humbert P.

Ann Dermatol Venereol. 2009 Oct;136(10):756-8. doi: 10.1016/j.annder.2009.04.016. Epub 2009 Jun 4. French. No abstract available.

PMID:
19801268
20.

Homelessness and high-dosage buprenorphine misuse.

Blanchon T, Boissonnas A, Vareseon I, Vidal-Trecan G.

Subst Use Misuse. 2003 Feb-May;38(3-6):429-42.

PMID:
12747392

Supplemental Content

Support Center